Custom Search

News

Thursday 01 August 2002

Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.

By: Asmus MJ, Hendeles L, Weinberger M, Ahrens RC, Bisgaard H, Lotvall J, O'Byrne PM, Cockcroft DW.

J Allergy Clin Immunol 2002 Aug;110(2):325; author reply 325-8

No abstract available

Use of this site is subject to the following terms of use